The Internal Dosimetry User Group, England, United Kingdom.
The Joint Department of Physics, The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, United Kingdom.
Br J Radiol. 2021 Oct 1;94(1126):20210547. doi: 10.1259/bjr.20210547. Epub 2021 Aug 25.
The Internal Dosimetry User Group (IDUG) is an independent, non-profit group of medical professionals dedicated to the promotion of dosimetry in molecular radiotherapy (www.IDUG.org.uk). The Ionising Radiation (Medical Exposure) Regulations 2017, IR(ME)R, stipulate a requirement for optimisation and verification of molecular radiotherapy treatments, ensuring doses to non-target organs are as low as reasonably practicable. For many molecular radiotherapy treatments currently undertaken within the UK, this requirement is not being fully met. The growth of this field is such that we risk digressing further from IR(ME)R compliance potentially delivering suboptimal therapies that are not in the best interest of our patients. For this purpose, IDUG proposes ten points of action to aid in the successful implementation of this legislation. We urge stakeholders to support these proposals and ensure national provision is sufficient to meet the criteria necessary for compliance, and for the future advancement of molecular radiotherapy within the UK.
内部剂量学用户组(IDUG)是一个独立的、非营利性的医学专业人员团体,致力于促进分子放疗中的剂量学(www.IDUG.org.uk)。2017 年《电离辐射(医疗照射)条例》(IR(ME)R)规定了优化和验证分子放疗治疗的要求,确保非靶器官的剂量尽可能低。对于目前在英国进行的许多分子放疗治疗,这一要求尚未得到充分满足。由于该领域的发展,我们有可能进一步偏离 IR(ME)R 合规,从而提供潜在的次优治疗方案,这不符合患者的最佳利益。为此,IDUG 提出了十点行动建议,以帮助成功实施这项法规。我们敦促利益相关者支持这些建议,确保国家规定足以满足合规所需的标准,并为英国分子放疗的未来发展提供支持。